Hims & Hers Health Reports Better-Than-Expected Q1 Results, Strong Guidance

Zinger Key Points
  • Hims & Hers reports GAAP earnings of 5 cents per share which beat the analyst consensus estimate of 2 cents by 150%.
  • Quarterly sales come in at $278.171 million which beat the analyst consensus estimate of $270.382 million by 2.88%.

Hims & Hers Health Inc HIMS reported its first-quarter financial results after the bell Monday. Here's a look at the highlights. 

The Details: Hims & Hers Health reported quarterly GAAP earnings of 5 cents per share which beat the analyst consensus estimate of 2 cents by 150%.

Quarterly sales came in at $278.171 million which beat the analyst consensus estimate of $270.382 million by 2.88% and represents a 45.81% increase over sales of $190.77 million from the same period last year.

Subscribers grew to 1.7 million, up 41% year-over-year in the first quarter.

“We are pleased to begin the year with exceptional results and strong momentum throughout the business,” said Andrew Dudum, CEO of Hims & Hers. “Our ability to deliver consistent performance across our key metrics is being fueled by our ability to capitalize on the increasing demand for high-quality, personalized solutions in each of our core specialties. During the period, we added a record number of net new subscribers, increasing 41% versus a year ago and bringing us to 1.7 million subscribers on the Hims & Hers platform. We also delivered our first quarter of double-digit net income profitability.”

Outlook: Hims & Hers sees second-quarter revenue of between $292 million and $297 million, versus the $288.073 million estimate.

The company sees full-year 2024 revenue in a range of $1.20 billion to $1.23 billion, versus the $1.191 billion estimate.

Related News: What’s Going On With Disney Stock Ahead Of Earnings?

HIMS Price Action: According to Benzinga Pro, Hims & Hers Health shares are up 10.90% after-hours at $12.92 at the time of publication Monday.

Photo: Courtesy of Hims & Hers Health, Inc.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsHealth CareAfter-Hours CenterMoverswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...